Changes and Continuities in the Global Health Governance of Coronaviruses
Abstract
This paper aims to examine changes and continuities in terms of actors and policies in the global health governance on coronaviruses in order to understand the available tools, the characters and the extent they meet the required responses of a pandemic. In doing so, this paper examines actors and policies in the governance of three occurrences of coronaviruses, i.e. SARS, MERS, and the COVID-19. Actors and policies are mapped based on its function in a pandemic: (a) surveillance and knowledge dissemination, (b) material and financial assistance both for emergency and long term purposes, and (c) rule-making behavior. This paper found that the larger scale of the COVID-19 pandemic has led more actors involved in the global governance of COVID-19 than during MERS and SARS. WHO still dominates the surveillance and knowledge dissemination as well as rule making leadership. It also leads in providing material assistance to affected countries. Yet, with the significant impacts to global economy, global financial institutions dominate the provision of financial assistance both for short term and long term commitment. This imbalanced crowd in this last aspect, therefore, causes a changing dominant approach of the GHG on coronaviruses from the previously dominating evidence-based scientific approach to economic approach.
Full Text:
PDFReferences
ADB. (n.d.). COVID-19. Retrieved April 2020, from ADB: https://www.adb.org/what-we-do/covid19-coronavirus
AIIB. (2020, April 3). AIIB Looks to Launch USD5 Billion COVID-19 Crisis Recovery Facility. Retrieved April 2020, from AIIB: https://www.aiib.org/en/news-events/news/2020/AIIB-Looks-to-Launch-USD5-Billion-COVID-19-Crisis-Recovery-Facility.html
Davies, S. (2018). Reporting Disease Outbreaks in a World with No Digital Borders. In C. McInnes, K. Lee, & J. Youde, The Oxford Handbook of Global Health Politics. Oxford: Oxford University Press.
Dion, M., AbdelMalik, P., & Mawudeku, A. (2015, September 3). Big Data and the Global Public Health Intelligence Network (GPHIN). Canada Communicable Disease Report, 41(9), 209-214.
FAO. (2020, February 19). MERS-CoV Situation Update. Retrieved from FAO: http://www.fao.org/ag/againfo/programmes/en/empres/mers/situation_update.html
FAO-OIE-WHO MERS Technical Working Group. (2018). MERS: Progress on the global response, remaining challenges and the way forward. Antiviral Research, 159, 35-44.
G20 Information Centre. (2020, March 26). Extraordinary G20 Leaders' Summit: Statement on COVID-19. Retrieved April 2020, from G20 Information Centre University of Toronto: http://www.g20.utoronto.ca/2020/2020-g20-statement-0326.html
Goldizen, F. C. (2016). From SARS to Avian Influenza: The Role of International Factors in China’s Approach to Infectious Disease Control. Annals of Global Health, 82(1), 180-188.
Heymann, D., & Rodier, G. (2004). SARS: A Global Response To An International Threat. Brown Journal of World Affairs, X(2), 186-196.
Huang, Y. (2004). The SARS Epidemic and Its Aftermath in China: A Political Perspective. In S. Knobler, A. Mahmoud, S. Lemon, A. Mack, L. Sivitz, & K. Oberholtzer, Learning from SARS Preparing for the Next Disease Outbreak. Washington, DC: National Academies Press.
Hurd, I. (2014). International Organizations: Politics, Law, Practice. Cambridge: Cambridge University Press.
ILO. (2004, March). SARS: Practical and administrative responses to an infectious disease in the workplace. Retrieved April 2020, from ILO: https://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---safework/documents/publication/wcms_108546.pdf
IMF. (2020a, March 2). How the IMF Can Help Countries Address Economic Effects of Coronavirus - An Infographic. Retrieved April 2020, from International Monetary Fund: https://www.imf.org/en/About/Factsheets/Sheets/2020/02/28/how-the-imf-can-help-countries-address-the-economic-impact-of-coronavirus/coronavirus-infographic
IMF. (2020b, April 9). The IMF's Response to COVID-19. Retrieved April 2020, from International Monetary Fund: https://www.imf.org/en/About/FAQ/imf-response-to-covid-19
Kim, K., Yoon, H., & Jung, K. (2017). Resilience in risk communication networks: Following the 2015 MERS response in South Korea. Journal of Contingencies and Crisis Management, 25, 148-159.
Lucey, D. R. (2014). Still Learning From the Earliest Known MERS Outbreak, Zarqa, Jordan, April 2012. Clinical Infectious Diseases, 59(9), 1234-1236.
Mackenzie et.al., J. S. (2014). The Global Outbreak Alert and Response Network. Global Public Health, 9(9), 1023-1039.
Mackenzie, J., & Merianos, A. (2013). The legacies of SARS – international preparedness and readiness to respond to future threats in the Western Pacifi c Region. Western Pacific Surveillance and Response Journal, 4(3), 1-5.
McInnes, C., Kamradt-Scott, A., Lee, K., Roemer-Mahler, A., Rushton, S., & Williams, O. (2014). The Transformation of Global Health Governance. Basingstoke: Palgrave Macmillan.
MSF. (2003, May 23). MSF opens program in China to help stop spread of SARS. Retrieved April 2020, from Medicine Sans Frontiere: https://www.msf.org/msf-opens-program-china-help-stop-spread-sars
Park, M., Thwaites, R., & Openshaw, P. (2020). COVID-19: Lessons from SARS and MERS. European Journal of Immunology, 50, 308-316.
Pertiwi, S. B. (2020, March 27). Indonesia’s Virus Response and What It Tells Us About Global Health Governance. Retrieved April 2020, from The Diplomat: https://thediplomat.com/2020/03/indonesias-virus-response-and-what-it-tells-us-about-global-health-governance/
Tanguay, F. (2019, November 12). GHPIN Global Public Health Intelligence Network. Retrieved April 2020, from WHO: https://www.who.int/docs/default-source/eios-gtm-2019-presentations/tanguay-phac---eios-gtm-2019.pdf?sfvrsn=8c758734_2
Weiss, T., & Thakur, R. (2010). Global Governance and the UN: An Unfinished Journey. Bloomington: Indiana University Press.
WHO (b). (n.d.). COVID-19 Response Fund. Retrieved April 2020, from WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/donors-and-partners/funding
WHO. (2003, December 31). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Retrieved April 2020, from WHO: https://www.who.int/csr/sars/country/table2004_04_21/en/
WHO. (2004a, October). WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). WHO. Retrieved from https://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1.pdf?ua=1
WHO. (2004b). WHO SARS Risk Assessment and Preparedness Framework. WHO.
WHO. (2005). International Health Regulations (2005) (Third Edition). Geneva: WHO.
WHO. (2009, July 27). Pandemic (H1N1) 2009 - update 59. Retrieved April 2020, from WHO: https://www.who.int/csr/don/2009_07_27/en/
WHO. (2010, August 6). Pandemic (H1N1) 2009 - update 112. Retrieved April 2020, from WHO: https://www.who.int/csr/don/2010_08_06/en/
WHO. (2012, September 23). Novel coronavirus infection in the United Kingdom. Retrieved April 2020, from WHO: https://www.who.int/csr/don/2012_09_23/en/
WHO. (2013, July 9). Middle East respiratory syndrome coronavirus (MERS-CoV). Retrieved April 2020, from WHO: https://www.who.int/ihr/procedures/statements_20130709/en/
WHO. (2017). Emergency Response Framework (Second Edition). Geneva.
WHO. (2019a, March 11). Middle East respiratory syndrome coronavirus (MERS-CoV). Retrieved April 2020, from WHO: https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)
WHO. (2019b, March 11). Middle East respiratory syndrome coronavirus (MERS-CoV): Key facts. Retrieved April 2020, from WHO: https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov)
WHO. (2020a). 2019 Novel Coronavirus (2019-nCoV): Strategic Preparedness and Response Plan. Geneva: WHO.
WHO. (2020b, April 8). Coronavirus (COVID-19). Retrieved from WHO: https://who.sprinklr.com
WHO. (2020c, April 8). Coronavirus disease 2019 (COVID-19) Situation Report – 79. Retrieved April 2020, from WHO: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200408-sitrep-79-covid-19.pdf?sfvrsn=4796b143_6
WHO. (2020d, January 20). Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1. Retrieved April 2020, from WHO: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4
WHO. (2020e, January 25). Novel Coronavirus (2019-nCoV) SITUATION REPORT - 5. Retrieved April 2020, from WHO: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov.pdf?sfvrsn=429b143d_8
WHO. (2020f, January 31). Novel Coronavirus(2019-nCoV) Situation Report - 11. Retrieved April 2020, from WHO: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4
WHO. (2020g, March 11). WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Retrieved April 2020, from WHO: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
WHO Regional Office for the Eastern Mediteranian. (2019, November). MERS Situation Update. Retrieved April 2020, from WHO: http://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&ua=1&ua=1
WHO. (n.d.). Severe Acute Respiratory Syndrome (SARS) - Travel. Retrieved April 2020, from WHO: https://www.who.int/csr/sars/travel/en/
WHO(a). (n.d.). Coronavirus disease (COVID-19) Pandemic. Retrieved April 2020, from WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
WHO(c). (n.d.). Current WHO phase of pandemic alert for Pandemic (H1N1) 2009. Retrieved April 2020, from WHO: https://www.who.int/csr/disease/swineflu/phase/en/
WHO(d). (n.d.). Epidemic Intelligence from Open Sources (EIOS). Retrieved April 2020, from WHO: https://www.who.int/eios
WHO(e). (n.d.). Global Outbreak Alert and Response Network (GOARN). Retrieved April 2020, from WHO: https://www.who.int/ihr/alert_and_response/outbreak-network/en/
WHO(f). (n.d.). IHR Emergency Committee concerning Middle East respiratory syndrome coronavirus. Retrieved April 2020, from WHO: https://www.who.int/ihr/ihr_ec_2013/en/
WHO(g). (n.d.). Partners and Networks. Retrieved April 2020, from WHO: https://www.who.int/emergencies/partners
WHO(h). (n.d.). R&D Blueprint. Retrieved April 2020, from WHO: https://www.who.int/blueprint/about/en/
WHO, FAO, OIE. (2019). Taking a Multisectoral, One Health Approach: A Tripartite Guide to Addressing Zoonotic Diseases in Countries. WHO, FAO, OIE.
World Bank. (2007, June 29). Implementation Completion and Results Report on Credit/Grant In the Amount of SDR 8.1 Million; US$ 8 Million to the People's Republic of China. Retrieved April 2020, from World Bank: http://documents.worldbank.org/curated/en/627391468214499938/pdf/401860pid0203733600BOX0334059B.pdf
World Bank. (2017, May 9). Pandemic Emergency Financing Facility: Frequently Asked Questions. Retrieved April 2020, from The World Bank: https://www.worldbank.org/en/topic/pandemics/brief/pandemic-emergency-facility-frequently-asked-questions
World Bank. (2020a, February 11). How the World Bank Group is helping countries with COVID-19 (coronavirus). Retrieved April 2020, from The World Bank: https://www.worldbank.org/en/news/factsheet/2020/02/11/how-the-world-bank-group-is-helping-countries-with-covid-19-coronavirus
World Bank. (2020b, March 17). World Bank Group Increases COVID-19 Response to $14 Billion To Help Sustain Economies, Protect Jobs. Retrieved April 2020, from The World Bank: https://www.worldbank.org/en/news/press-release/2020/03/17/world-bank-group-increases-covid-19-response-to-14-billion-to-help-sustain-economies-protect-jobs
Youde, J. (2015). MERS and Global Health Governance. International Journal, 70(1), 119-136.
Zacher, M., & Keefe, T. (2008). The Politics of Global Health Governance: United by Contagion. New York: Palgrave Macmillan.
Refbacks
- There are currently no refbacks.
